SEC Form 4 · accession 0001621170-15-000003
Immunoclin Corp · IMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
DH Bray
Officer — President, CEO · Director · 10% Owner
Period of report
Jun 5, 2015
Accepted (ET)
Jun 9, 2015 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520047
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2015 | A | 1,000,000 | $4.00 | A | 2,000,000 | I | Held by BDH Holding BV, a company which Dr. Bray has voting and investment control over. |
| Common Stock | holding | — | — | — | 10,000,000 | D | ||
| Series A Preferred Stock | holding | — | — | — | 370,000 | I | Held by BDH Holding BV, a company which Dr. Bray has voting and investment control over. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options | $1.45 | holding | — | — | — | Nov 1, 2014 | Nov 1, 2019 | Common Stock | 1,000,000 | 1,000,000 | D |